Market Tracker

02/05 5:16pm ET

Rxi Pharmaceuticals Corp (NASDAQ:RXII)

0.2896
Delayed Data
As of Feb 05
 -0.0062 / -2.10%
Today’s Change
0.27
Today|||52-Week Range
1.73
-24.19%
Year-to-Date
No recent news for Rxi Pharmaceuticals Corp.

Today’s Trading

Previous close0.30
Today’s open0.30
Day’s range0.28 - 0.31
Volume89,827
Average volume (3 months)707,900
Market cap$18.9M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+72.57%
Earnings growth (this year)+73.84%
Earnings growth (next 5 years)--
Revenue growth (last year)-82.21%
P/E ratioNM
Price/Sales368.74
Price/Book5.46

Competitors

 Today’s
change
Today’s
% change
OXGNOXiGENE Inc-0.01-1.60%
ROSGRosetta Genomics Ltd+0.02+2.30%
RGBPRegen BioPharma Inc+0.01+12.46%
GENEGenetic Technologies...-0.08-3.65%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 28, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$71.0K
Annual profit (last year)-$8.8M
Net profit margin-12,394.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Geert Cauwenbergh
Vice President-
Research
Karen Bulock
Corporate headquarters
Marlborough, Massachusetts

Forecasts